EPISODE · Jan 31, 2025 · 21 MIN
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 20 Safety Considerations Beyond the Lab (Societal and Ethical Implications)
from Cannabinoid and Psychedelic Pharmacology and Drug Development
This podcast episode explores the societal safety implications of cannabinoids and psychedelics, covering key topics like addiction potential, psychological risks, and substance misuse. The discussion examines how regulatory frameworks and quality control measures like cGMP compliance can help ensure public safety. The episode also delves into the FDA's role in drug approval, the importance of accurate labeling, and the broader ethical considerations of integrating these substances into mainstream use.
NOW PLAYING
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 20 Safety Considerations Beyond the Lab (Societal and Ethical Implications)
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.